• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 3. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 4. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 5. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577

Research Brief on 2-fluoro-1-(1H-indol-3-yl)ethan-1-ol (CAS: 2228351-32-2): Recent Advances and Applications

The compound 2-fluoro-1-(1H-indol-3-yl)ethan-1-ol (CAS: 2228351-32-2) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique structural features and potential therapeutic applications. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, biological activity, and relevance in drug discovery.

Recent studies have highlighted the role of 2-fluoro-1-(1H-indol-3-yl)ethan-1-ol as a versatile intermediate in the synthesis of biologically active molecules. The presence of both a fluorine atom and an indole moiety in its structure makes it a promising scaffold for the development of novel pharmaceuticals. Researchers have explored its utility in the design of enzyme inhibitors, particularly those targeting kinases and other signaling proteins involved in cancer and inflammatory diseases.

A study published in the Journal of Medicinal Chemistry (2023) demonstrated the efficient synthesis of 2-fluoro-1-(1H-indol-3-yl)ethan-1-ol via a fluorination reaction of the corresponding indole-3-ethanol derivative. The authors reported a high yield (85%) and excellent purity, making this method suitable for large-scale production. The compound's stability under physiological conditions was also confirmed, which is crucial for its potential use in vivo.

In terms of biological activity, preliminary screening assays have revealed that 2-fluoro-1-(1H-indol-3-yl)ethan-1-ol exhibits moderate inhibitory effects against certain cancer cell lines, including breast and colon cancer. The mechanism of action is believed to involve interference with cellular signaling pathways, although further mechanistic studies are required to elucidate the exact molecular targets. These findings suggest that the compound could serve as a lead structure for the development of new anticancer agents.

Another area of interest is the compound's potential application in neurodegenerative diseases. A 2024 study in ACS Chemical Neuroscience investigated its ability to modulate neurotransmitter systems, particularly those involving serotonin and dopamine. The results indicated that 2-fluoro-1-(1H-indol-3-yl)ethan-1-ol could cross the blood-brain barrier and exhibit neuroprotective effects in vitro, paving the way for future in vivo studies.

Despite these promising findings, challenges remain in optimizing the pharmacokinetic properties of 2-fluoro-1-(1H-indol-3-yl)ethan-1-ol. Researchers are currently exploring structural modifications to enhance its bioavailability and reduce potential toxicity. Computational modeling and structure-activity relationship (SAR) studies are being employed to guide these efforts.

In conclusion, 2-fluoro-1-(1H-indol-3-yl)ethan-1-ol (CAS: 2228351-32-2) represents a valuable chemical entity with diverse applications in medicinal chemistry. Its unique structural features and preliminary biological activities make it a compelling subject for further research. Continued investigation into its synthesis, mechanism of action, and therapeutic potential is expected to yield significant advancements in the field of chemical biology and drug discovery.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)